Radvax
Phase 1Biologic
Radvax is one of 26 biologic programs targeting Vaccine. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
25
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
36 competitors in Vaccine
#DrugCompanyPhaseTrials
1Rotarix ™
GSKPhase 3
Havrix
GSKPhase 3
Rotateq
Merck & Co.Phase 3
Vaxelis Vaccine
SanofiPhase 3
Varivax
GSKPhase 3
M-M-R II Vaccine
SanofiPhase 3
Priorix
GSKPhase 3
Trumenba
PfizerPhase 3
Bayer Aspirin
BayerPhase 1
Varivax Vaccine
SanofiPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Radvax. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 1[1]
- Company
- VVaxine Pty Ltd